Cargando…
The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis
Pulmonary arterial hypertension, categorized as group 1 pulmonary hypertension by the World Health Organization classification system, represents a major complication of systemic sclerosis resulting from pulmonary vascular involvement of the disease. The high mortality seen in systemic sclerosis-ass...
Autores principales: | Lee, Michael H, Bull, Todd M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971837/ https://www.ncbi.nlm.nih.gov/pubmed/32025283 http://dx.doi.org/10.12688/f1000research.20313.1 |
Ejemplares similares
-
Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019) -
Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis
por: Almaaitah, Saja, et al.
Publicado: (2020) -
The Potential Application and Promising Role of Targeted Therapy in Pulmonary Arterial Hypertension
por: Hsieh, Meng-Chien Willie, et al.
Publicado: (2022) -
Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension
por: Pugliese, Steven C, et al.
Publicado: (2016) -
Pulmonary Arterial Hypertension In Systemic Sclerosis: Challenges In Diagnosis, Screening And Treatment
por: Saygin, Didem, et al.
Publicado: (2019)